Endocrine Regulations (Jan 2016)

Pancrelipase treatment in a patient with the history of Roux-en-Y gastric bypass operation that developed resistant hypocalcemia secondary to total thyroidectomy

  • Baldane S,
  • Ipekci SH,
  • Kebapcilar L

DOI
https://doi.org/10.1515/enr-2016-0006
Journal volume & issue
Vol. 50, no. 1
pp. 27 – 31

Abstract

Read online

Objective. Roux-en-Y gastric bypass (RYGB) is an independent risk factor for moderate hypocalcaemia and may lead to the development of resistant hypocalcaemia following thyroid surgery.

Keywords